Pfizer has agreed to pay $60 million to resolve allegations brought by the US government that its Biohaven Pharma subsidiary ...
In last year's update, AbbVie raised the combined 2027 net sales guidance for Skyrizi and Rinvoq by $6 billion to $27 billion ...
We recently published a list of 11 Best Bear Market Stocks To Invest In Now. In this article, we are going to take a look at ...
William Blair reduced their FY2024 EPS estimates for shares of AbbVie in a research note issued on Tuesday, January 21st.
To subscribe to Barron's, visit http://www.barrons.com/subscribe January 24, 2025 21:45 ET (02:45 GMT) ...
Buying $1000 In ABBV: If an investor had bought $1000 of ABBV stock 5 years ago, it would be worth $2,026.90 today based on a ...
EPS of $6.84, compared to $5.33 in the prior-year quarter. Tesla Inc (NASDAQ: TSLA) (Q4) EPS of 64 cents, compared to 57 cents in the prior-year quarter. BoC Interest Rate Decision (Jan.) The Bank of ...
Merck and Eisai reported new data for a drug regimen of Keytruda and Lenvima. Elsewhere, AstraZeneca expanded in Canada and ...
AbbVie Inc (ABBV) stock saw a modest uptick, ending the day at $170.67 which represents a slight increase of $1.47 or 0.87% from the prior close of $169.2. The stock opened at $170.46 and touched a ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
A daily rundown of the economic reports and corporate earnings that will be grabbing the market’s attention in the week ahead ...
In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on AbbVie (ABBV – Research Report), with a price target ...